IDEX Corporation (IEX) › Analysis

IDEX (IEX) stock analysis, November 3, 2026: Record quarter supports uptrend; breakout math still thin

Published November 3, 2026 · IEX chart, levels and live analysis

IDEX Corporation (IEX) reported record third-quarter results on October 28, 2026 and raised its full-year guidance. The stock has stayed near $237 since, 1.3% below its 52-week high. The balance of evidence leans positive for the next two to six weeks, with medium conviction. The trend is up on both the daily and weekly charts, but the price sits just under resistance, so the math for a breakout is thin.

Why it matters

The quarter was clean. Sales reached $952 million, up 8% on both a reported and organic basis, and orders rose 13% to $991 million. Adjusted earnings per share were a record $2.33, up 15%, and gross margin widened by 60 basis points to 45.1%, according to the company's SEC 8-K filing. Management then raised the full-year outlook to 6.5%–6.8% organic growth and adjusted EPS of $8.91–$8.96, as Seeking Alpha reported, pointing to data centers, semiconductor, space and defense, and water. Orders growing faster than sales matters most here. It suggests the coming quarters have demand behind them.

The market recognized this quickly and then stopped. The stock's recent peak close was $239.33 on October 29, the day after the report. At $237.39 it sits 0.8% below that, and it is up 2.0% over the past month. Volume today is 56.8% below its 20-day average. Nobody is rushing in or out. The good news looks absorbed rather than still being digested.

Over the past five days IEX rose 1.9% while the S&P 500 (SPY) fell 2.0%, so the market did not lift this stock. No sector ETF figure is available, so the sector's share of the move cannot be separated out. The news I have does not explain why the broad market fell. What the data does show is persistent relative strength: IEX leads the S&P 500 by 4.9 points over 50 days and by 6.1 points over 200 days. Year to date it is up 33.5% against 10.6% for SPY.

The real argument is about how much of this growth is already in the price. A Seeking Alpha piece from October 25, written before the report, took a neutral stance. Its author said the stock has been growing nicely but not enough to justify a bullish rating. The case on the other side is the quarter itself: record earnings, 13% order growth and a higher guide. The report answered part of the skeptic's point, since growth is accelerating in orders. It did not settle whether that is worth a price already 33.5% higher this year.

Analysts lean toward the second view only mildly. Fourteen of them rate the stock a consensus buy, with a mean price target of $262.93 and a range from $228 to $283. The shares trade 9.7% below the mean target, and the lowest target sits below today's price. So the spread is wide, and some analysts already see the stock as fully priced.

What the evidence says

The long-term thesis is intact. Price is above both its 10-week and 40-week averages, and the 50-day average at $230.24 is well above the 200-day at $216.63. The stock is 46.8% above its 52-week low of $161.68 and about 1.3% below the high of $240.52. This is a mature uptrend pausing just under its highs after an earnings-driven push, not a stock recovering from damage.

For the next two to six weeks the balance of evidence leans positive, with medium conviction: two of four points. Two things support it. The daily trend runs with the weekly uptrend, and IEX is leading the S&P 500 over 50 days by 4.9%. Conviction is not higher because the other two points are missing. Momentum is neutral, with the 14-day RSI at 48.4, and the post-earnings volume is thin.

The strongest case against the positive reading is the proximity of resistance. The 52-week high at $240.52 and a swing zone at $241.88 are within a few dollars of the current price. Volume has dried up, which means the move to $239.33 was not followed by fresh buying. If buyers do not return, the stock can drift back toward the 50-day average. This does not tip the balance, because the trend and relative strength are still intact and nothing in the structure has broken. It is the reason conviction stops at medium.

Levels that matter

The structure holds above $230.94, a swing zone that sits just above the 50-day average at $230.24. A close below it would be the first crack. Under that, $225 is a round-number support. The trend ends below $217.64, another swing zone, with the 200-day average at $216.63 right beneath it. Those two lines make that area the floor for the long-term uptrend.

The breakout level is a daily close above $240.52, the 52-week high, on volume above its 20-day average. The math from there is poor. The first target is $241.88, the next swing zone, and a stop at $229.37 (the $230.94 zone minus a quarter of the 14-day ATR of $6.30) gives a reward-to-risk of 0.1 to 1. That does not reach 3 to 1. Only a much more distant target, or a price much closer to the stop, would change that. The next marked levels above are the round numbers $250 and $275.

What would change the picture

A weekly close below $217.64 would change the picture, because it would end the weekly uptrend that the whole positive reading depends on. The non-price fact that could do it is a break in the order trend. If organic orders, up 13% in the third quarter, turned down, or if management cut the guidance it just raised, the argument that growth justifies the price would lose its main support.

What to watch

Get a message when the IEX picture changes — the agent team watches the levels and the news for you.Create a free account

More IEX analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.